{"id":208,"date":"2025-01-13T00:00:00","date_gmt":"2025-01-12T23:00:00","guid":{"rendered":"https:\/\/www.aescap.com\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/"},"modified":"2026-06-30T08:47:04","modified_gmt":"2026-06-30T07:47:04","slug":"intra-cellular-therapeutics-overgenomen-door-johnson-johnson","status":"publish","type":"post","link":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/","title":{"rendered":"Intra-Cellular Therapeutics overgenomen door Johnson &#038; Johnson"},"content":{"rendered":"<p>Johnson &amp; Johnson neemt Intra-Cellular Therapeutics over, een bedrijf uit onze portfolio dat zich richt op innovatieve behandelingen voor neurologische aandoeningen. De overname bevestigt de waarde van onze selectiemethodiek en levert een aantrekkelijk rendement op voor onze beleggers.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Vandaag kondigde Johnson &amp; Johnson (J&amp;J) de overname aan van Intra-Cellular Therapeutics. J&amp;J neemt dit Aescap Life Sciences portfoliobedrijf over voor $132 per aandeel. Een premie van 39% ten opzichte van de slotkoers van vrijdag ($94,87). De dealwaarde bedraagt $14,6 miljard.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De overnamepremie van 39% lijkt misschien niet hoog. Er zat echter al wat overnamespeculatie in de koers die daardoor al eerder omhoog was gegaan. Daarnaast geldt veelal: hoe hoger het absolute bedrag des te lager de overnamepremie in procenten.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aescap investeerde in juni 2023 in Intra-Cellular op een koers van $61. Voor de aankondiging van de overname vertegenwoordigde de positie 7,5% van de portefeuille van het Life Sciences fonds.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Intra-Cellular Therapies ontwikkelt medicijnen voor neurologische aandoeningen. Het heeft op dit moment 1 medicijn op de markt. Caplyta, goedgekeurd voor de behandeling van bipolaire stoornissen en schizofrenie. Goedkeuring voor de behandeling van depressie is in aanvraag. Daarnaast heeft het meerdere klinische studies lopen. Onder andere voor psychose geassocieerd met de ziekte van Alzheimer en Parkinson.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson neemt Intra-Cellular Therapeutics over, een bedrijf uit onze portfolio dat zich richt op innovatieve behandelingen voor neurologische aandoeningen. De overname bevestigt de waarde van onze selectiemethodiek en levert een aantrekkelijk rendement op voor onze beleggers. Vandaag kondigde Johnson &amp; Johnson (J&amp;J) de overname aan van Intra-Cellular Therapeutics. J&amp;J neemt dit Aescap Life [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,1],"tags":[],"class_list":["post-208","post","type-post","status-publish","format-standard","hentry","category-niet-gecategoriseerd","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intra-Cellular Therapeutics overgenomen door Johnson &amp; Johnson - Aescap<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intra-Cellular Therapeutics overgenomen door Johnson &amp; Johnson - Aescap\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson neemt Intra-Cellular Therapeutics over, een bedrijf uit onze portfolio dat zich richt op innovatieve behandelingen voor neurologische aandoeningen. De overname bevestigt de waarde van onze selectiemethodiek en levert een aantrekkelijk rendement op voor onze beleggers. Vandaag kondigde Johnson &amp; Johnson (J&amp;J) de overname aan van Intra-Cellular Therapeutics. J&amp;J neemt dit Aescap Life [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/\" \/>\n<meta property=\"og:site_name\" content=\"Aescap\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-12T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-30T07:47:04+00:00\" \/>\n<meta name=\"author\" content=\"Victor Bakker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Victor Bakker\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/nl\\\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aescap.com\\\/nl\\\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\\\/\"},\"author\":{\"name\":\"Victor Bakker\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#\\\/schema\\\/person\\\/fdf0cba45cbdda766055ddd8559df459\"},\"headline\":\"Intra-Cellular Therapeutics overgenomen door Johnson &#038; Johnson\",\"datePublished\":\"2025-01-12T23:00:00+00:00\",\"dateModified\":\"2026-06-30T07:47:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aescap.com\\\/nl\\\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\\\/\"},\"wordCount\":204,\"publisher\":{\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#organization\"},\"articleSection\":[\"Niet-gecategoriseerd\",\"Uncategorized\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/nl\\\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\\\/\",\"url\":\"https:\\\/\\\/www.aescap.com\\\/nl\\\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\\\/\",\"name\":\"Intra-Cellular Therapeutics overgenomen door Johnson & Johnson - Aescap\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#website\"},\"datePublished\":\"2025-01-12T23:00:00+00:00\",\"dateModified\":\"2026-06-30T07:47:04+00:00\",\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aescap.com\\\/nl\\\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#website\",\"url\":\"https:\\\/\\\/www.aescap.com\\\/\",\"name\":\"Aescap\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aescap.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#organization\",\"name\":\"Aescap\",\"url\":\"https:\\\/\\\/www.aescap.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.aescap.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/cropped-logo2021_restyle_180.png\",\"contentUrl\":\"https:\\\/\\\/www.aescap.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/cropped-logo2021_restyle_180.png\",\"width\":180,\"height\":121,\"caption\":\"Aescap\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aescap.com\\\/#\\\/schema\\\/person\\\/fdf0cba45cbdda766055ddd8559df459\",\"name\":\"Victor Bakker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d4dc29cbd28bb32fc5ca5643f68112ac183a61b9dd52341f5b09242eee83049b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d4dc29cbd28bb32fc5ca5643f68112ac183a61b9dd52341f5b09242eee83049b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d4dc29cbd28bb32fc5ca5643f68112ac183a61b9dd52341f5b09242eee83049b?s=96&d=mm&r=g\",\"caption\":\"Victor Bakker\"},\"url\":\"https:\\\/\\\/www.aescap.com\\\/nl\\\/author\\\/victorbakker\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intra-Cellular Therapeutics overgenomen door Johnson & Johnson - Aescap","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/","og_locale":"nl_NL","og_type":"article","og_title":"Intra-Cellular Therapeutics overgenomen door Johnson & Johnson - Aescap","og_description":"Johnson &amp; Johnson neemt Intra-Cellular Therapeutics over, een bedrijf uit onze portfolio dat zich richt op innovatieve behandelingen voor neurologische aandoeningen. De overname bevestigt de waarde van onze selectiemethodiek en levert een aantrekkelijk rendement op voor onze beleggers. Vandaag kondigde Johnson &amp; Johnson (J&amp;J) de overname aan van Intra-Cellular Therapeutics. J&amp;J neemt dit Aescap Life [&hellip;]","og_url":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/","og_site_name":"Aescap","article_published_time":"2025-01-12T23:00:00+00:00","article_modified_time":"2026-06-30T07:47:04+00:00","author":"Victor Bakker","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Victor Bakker","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/#article","isPartOf":{"@id":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/"},"author":{"name":"Victor Bakker","@id":"https:\/\/www.aescap.com\/#\/schema\/person\/fdf0cba45cbdda766055ddd8559df459"},"headline":"Intra-Cellular Therapeutics overgenomen door Johnson &#038; Johnson","datePublished":"2025-01-12T23:00:00+00:00","dateModified":"2026-06-30T07:47:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/"},"wordCount":204,"publisher":{"@id":"https:\/\/www.aescap.com\/#organization"},"articleSection":["Niet-gecategoriseerd","Uncategorized"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/","url":"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/","name":"Intra-Cellular Therapeutics overgenomen door Johnson & Johnson - Aescap","isPartOf":{"@id":"https:\/\/www.aescap.com\/#website"},"datePublished":"2025-01-12T23:00:00+00:00","dateModified":"2026-06-30T07:47:04+00:00","inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.aescap.com\/#website","url":"https:\/\/www.aescap.com\/","name":"Aescap","description":"","publisher":{"@id":"https:\/\/www.aescap.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aescap.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.aescap.com\/#organization","name":"Aescap","url":"https:\/\/www.aescap.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.aescap.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.aescap.com\/wp-content\/uploads\/2026\/02\/cropped-logo2021_restyle_180.png","contentUrl":"https:\/\/www.aescap.com\/wp-content\/uploads\/2026\/02\/cropped-logo2021_restyle_180.png","width":180,"height":121,"caption":"Aescap"},"image":{"@id":"https:\/\/www.aescap.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.aescap.com\/#\/schema\/person\/fdf0cba45cbdda766055ddd8559df459","name":"Victor Bakker","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/d4dc29cbd28bb32fc5ca5643f68112ac183a61b9dd52341f5b09242eee83049b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d4dc29cbd28bb32fc5ca5643f68112ac183a61b9dd52341f5b09242eee83049b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4dc29cbd28bb32fc5ca5643f68112ac183a61b9dd52341f5b09242eee83049b?s=96&d=mm&r=g","caption":"Victor Bakker"},"url":"https:\/\/www.aescap.com\/nl\/author\/victorbakker\/"}]}},"_links":{"self":[{"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/posts\/208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/comments?post=208"}],"version-history":[{"count":2,"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/posts\/208\/revisions"}],"predecessor-version":[{"id":1705,"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/posts\/208\/revisions\/1705"}],"wp:attachment":[{"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/media?parent=208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/categories?post=208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aescap.com\/nl\/wp-json\/wp\/v2\/tags?post=208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}